세계의 생명과학 툴 시장 : 기술, 제품, 제공, 랩 소유자, 랩 규모, 최종 사용자별 예측(2025-2030년)

The Life Science Tools Market was valued at USD 203.93 billion in 2023, expected to reach USD 226.14 billion in 2024, and is projected to grow at a CAGR of 11.21%, to USD 429.19 billion by 2030.

The Life Science Tools market encompasses a wide range of instruments, reagents, and consumables used in biological research. These tools are essential for applications in genomics, proteomics, cell biology, and diagnostics, among other areas. Their necessity lies in supporting scientific advancements and healthcare innovations, especially in drug discovery, disease research, and personalized medicine. The end-use scope includes academia, pharmaceutical and biotechnology companies, clinical research organizations, and diagnostic laboratories. Key growth factors influencing this market include advancements in technology, increased funding for research and development, and a growing focus on precision medicine. In particular, rapid developments in sequencing technologies and high-throughput screening methods present significant potential opportunities. Companies should invest in these areas to tap into the rising demand for sophisticated analytical capabilities. However, market growth is challenged by factors such as high costs of sophisticated tools, regulatory hurdles, and the need for skilled personnel. Furthermore, the dynamic nature of technology can render tools obsolete quickly, adding pressure to stay at the forefront of innovation. Opportunities lie in areas such as miniaturization of equipment, integration of artificial intelligence for data analysis, and development of more cost-effective and user-friendly tools. Enhancements in cloud computing and digitalization also offer new avenues for innovation, enabling better data management and collaborative research. Despite these opportunities, the market is highly competitive, requiring companies to strategically navigate intellectual property challenges and ensure compliance with stringent regulations. Businesses must prioritize innovative research, form strategic partnerships, and focus on customer-centric approaches to maintain competitive advantages. Overall, the life science tools market is poised for continued growth, driven by technological advancements and increasing demand for high-precision research tools, though it requires navigating a landscape of rapid innovation and regulatory complexities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Life Science Tools Market

The Life Science Tools Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need for efficient tools for early diagnosis of chronic diseases
  • Surge in investments toward biotech R&D activities from government and non-government organizations
  • Applications of genomic and proteomic technologies for precision medicine
• Market Restraints
  • High cost of life science tools
• Market Opportunities
  • Robust technological advancements in life science tools
  • Rapid progress and development of life-science tools in the single-cell isolation and analysis
• Market Challenges
  • Quality control issues associated with life science tools

Porter's Five Forces: A Strategic Tool for Navigating the Life Science Tools Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Life Science Tools Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Life Science Tools Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Life Science Tools Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Life Science Tools Market

A detailed market share analysis in the Life Science Tools Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Life Science Tools Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Life Science Tools Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Luminex Corporation, SGS SA, Fulgent Genetics, Inc., Merck KGaA, Danaher Corporation, Promega Corporation, Eurofins Scientific SE, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Avantor, Inc., IQVIA Holdings Inc., Repligen Corporation, Lonza Group Ltd., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Hitachi, Ltd., Mettler-Toledo International Inc., Abbott Laboratories, Bio-Techne Corporation, Becton, Dickinson, and Company, Tecan Trading AG, B. Braun SE, New England Biolabs, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Bruker Corporation, HORIBA, Ltd., 3M Company, Waters Corporation, Charles River Laboratories International, Inc., GE Healthcare Technologies Inc., Carl Zeiss AG, PerkinElmer, Inc., Oxford Instruments PLC, ICON PLC, Abcam PLC, Shimadzu Corporation, Takara Bio Inc., Diagnostica Longwood S.L., Illumina, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Genscript Biotech Corporation, 10x Genomics, Inc., Eppendorf SE, WuXi AppTec Co., Ltd, and bioMerieux SA.

Market Segmentation & Coverage

This research report categorizes the Life Science Tools Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Cell Biology Technology, Genomic Technology, and Proteomics Technology.
• Based on Product, market is studied across Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry, Liquid Chromatography, Mass Spectrometry, Microscopy & Electron Microscopy, Next Generation Sequencing, Nuclear Magnetic Resonance, Nucleic Acid Microarray, Nucleic Acid Preparation, PCR & qPCR, Sanger Sequencing, and Transfection Devices & Gene Delivery Technologies. The Cell Culture Systems & 3D Cell Culture is further studied across Media, Reagents, and Sera.
• Based on Offerings, market is studied across Consumables, Instrument, and Services.
• Based on Lab Ownership, market is studied across Private and Public.
• Based on Lab Size, market is studied across Large, Medium, and Small.
• Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organization/ Contract Manufacturing Organization, Diagnostic Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for efficient tools for early diagnosis of chronic diseases
    • 5.1.1.2. Surge in investments toward biotech R&D activities from government and non-government organizations
    • 5.1.1.3. Applications of genomic and proteomic technologies for precision medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of life science tools
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust technological advancements in life science tools
    • 5.1.3.2. Rapid progress and development of life-science tools in the single-cell isolation and analysis
  • 5.1.4. Challenges
    • 5.1.4.1. Quality control issues associated with life science tools
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
  • 5.2.2. End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Life Science Tools Market, by Technology

• 6.1. Introduction
• 6.2. Cell Biology Technology
• 6.3. Genomic Technology
• 6.4. Proteomics Technology

7. Life Science Tools Market, by Product

• 7.1. Introduction
• 7.2. Cell Culture Systems & 3D Cell Culture
  • 7.2.1. Media
  • 7.2.2. Reagents
  • 7.2.3. Sera
• 7.3. Cloning & Genome Engineering
• 7.4. Flow Cytometry
• 7.5. Liquid Chromatography
• 7.6. Mass Spectrometry
• 7.7. Microscopy & Electron Microscopy
• 7.8. Next Generation Sequencing
• 7.9. Nuclear Magnetic Resonance
• 7.10. Nucleic Acid Microarray
• 7.11. Nucleic Acid Preparation
• 7.12. PCR & qPCR
• 7.13. Sanger Sequencing
• 7.14. Transfection Devices & Gene Delivery Technologies

8. Life Science Tools Market, by Offerings

• 8.1. Introduction
• 8.2. Consumables
• 8.3. Instrument
• 8.4. Services

9. Life Science Tools Market, by Lab Ownership

• 9.1. Introduction
• 9.2. Private
• 9.3. Public

10. Life Science Tools Market, by Lab Size

• 10.1. Introduction
• 10.2. Large
• 10.3. Medium
• 10.4. Small

11. Life Science Tools Market, by End-User

• 11.1. Introduction
• 11.2. Academic Research Institutes
• 11.3. Biotechnology Companies
• 11.4. Contract Research Organization/ Contract Manufacturing Organization
• 11.5. Diagnostic Laboratories
• 11.6. Hospitals

12. Americas Life Science Tools Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Life Science Tools Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Life Science Tools Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Bruker advances NMR magnet portfolio, innovates in industrial solutions
  • 15.3.2. BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
  • 15.3.3. UK boosts life science innovation with £277 million funding
  • 15.3.4. Illumina, GenoScreen launched next-generation sequencing innovation to eliminate TB
  • 15.3.5. Berkeley Lights Completed Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
  • 15.3.6. Waters Corporation launched the next generation Alliance iS HPLC System
  • 15.3.7. Patient Square Capital Partnered with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities
  • 15.3.8. GenScript expands footprint in Singapore to provide premium Gene Synthesis service
  • 15.3.9. SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo MS system
  • 15.3.10. Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado
  • 15.3.11. Cytek Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
  • 15.3.12. Tecan collaborates with Element Biosciences to provide benchtop NGS
  • 15.3.13. Agilent to collaborate with Quest Diagnostics to extend access to the Agilent Resolution ctDx FIRST Liquid Biopsy test
  • 15.3.14. Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
  • 15.3.15. Novo Holdings invests in a proteomics technology company, Evosep
  • 15.3.16. Agilent Acquired Life Sciences Company Avida Biomed
  • 15.3.17. QIAGEN and Helix Launched Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
  • 15.3.18. Bruker enters into a strategic partnership with Biognosys
  • 15.3.19. Charles River Labs expands CGT capabilities into Cheshire
  • 15.3.20. Neogen Launches New Genomic Management Technology
  • 15.3.21. MedGenome Raises USD 50M To Map The Human Genome
  • 15.3.22. Thermo Fisher Launches Next-Generation Sequencing Platform for Labs

Companies Mentioned

• 1. Cardinal Health, Inc.
• 2. Luminex Corporation
• 3. SGS SA
• 4. Fulgent Genetics, Inc.
• 5. Merck KGaA
• 6. Danaher Corporation
• 7. Promega Corporation
• 8. Eurofins Scientific SE
• 9. Agilent Technologies, Inc.
• 10. Bio-Rad Laboratories, Inc.
• 11. Avantor, Inc.
• 12. IQVIA Holdings Inc.
• 13. Repligen Corporation
• 14. Lonza Group Ltd.
• 15. QIAGEN N.V.
• 16. F. Hoffmann-La Roche Ltd.
• 17. Hitachi, Ltd.
• 18. Mettler-Toledo International Inc.
• 19. Abbott Laboratories
• 20. Bio-Techne Corporation
• 21. Becton, Dickinson, and Company
• 22. Tecan Trading AG
• 23. B. Braun SE
• 24. New England Biolabs, Inc.
• 25. Laboratory Corporation of America Holdings
• 26. Quest Diagnostics Incorporated
• 27. Bruker Corporation
• 28. HORIBA, Ltd.
• 29. 3M Company
• 30. Waters Corporation
• 31. Charles River Laboratories International, Inc.
• 32. GE Healthcare Technologies Inc.
• 33. Carl Zeiss AG
• 34. PerkinElmer, Inc.
• 35. Oxford Instruments PLC
• 36. ICON PLC
• 37. Abcam PLC
• 38. Shimadzu Corporation
• 39. Takara Bio Inc.
• 40. Diagnostica Longwood S.L.
• 41. Illumina, Inc.
• 42. Sartorius AG
• 43. Thermo Fisher Scientific Inc.
• 44. Genscript Biotech Corporation
• 45. 10x Genomics, Inc.
• 46. Eppendorf SE
• 47. WuXi AppTec Co., Ltd
• 48. bioMerieux SA